Netilmicin alone or in combination in renal transplantation. 1987

C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
Nephrology Department, Laikon General Hospital, Athens, Greece.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009428 Netilmicin Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. Certomycin,Netillin,Netilmicin Sulfate,Netrocin,Netromicina,Netromycin,Netromycine,Nétromicine,Sch-20569,Sch 20569,Sch20569
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D009950 Ornidazole A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action. Ro 7-0207,Ro-70207,Ro7-0207,Tiberal,Ro 7 0207,Ro 70207,Ro7 0207,Ro70207
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
October 1984, Transplantation proceedings,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
April 1989, Pathologie-biologie,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
October 1988, Clinical pharmacology and therapeutics,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
October 1983, Klinische Wochenschrift,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
July 2016, Infectious diseases (London, England),
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
January 2013, PloS one,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
October 2009, Clinical advances in hematology & oncology : H&O,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
January 2009, Angiology,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
August 1997, Arzneimittel-Forschung,
C Stathakis, and J Kosmidis, and J Boletis, and C Iatrou, and G Metaxatos, and T Vlassis, and J Chomatas, and G Vosnides
May 1996, Acta urologica Belgica,
Copied contents to your clipboard!